Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies

Biological Psychiatry(2024)10.1016/j.biopsych.2024.10.024Source: DataRank Database

The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies is a research paper published in Biological Psychiatry (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.32)OA: hybridTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Rebecca Rohac,Iya Cooper,Angela Griffo ORCID,Nastasia Mcdonald,Crystal Spotts

Live enrichment

PubMed:39581291 PMC:PMC11954668 OpenAlex:https://openalex.org/W4404626782

National Institutes of Health

Grant: UL1-TR-001857

National Institute of Mental Health

Grant: NCT04916548

National Institute of Mental Health

Grant: NCT05168735

National Institute of Mental Health

Grant: K23 MH119225

NCATS NIH HHS

Grant: UL1 TR001857

FWCI

0.32

Citation Percentile

0.6%

Citation Trend

2025

hybridLicense: cc-by

journalhttps://www.biologicalpsychiatryjournal.com/article/S0006-3223(24)01758-X/pdf

publisherhttps://www.biologicalpsychiatryjournal.com/article/S0006-3223(24)01758-X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S000632232401758X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S000632232401758X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.biopsych.2024.10.024

Fields of Study

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Research TopicsHumansKetamineMaleFemaleAdultAttentional BiasAntidepressive AgentsMiddle AgedReproducibility of ResultsYoung AdultMajor Depressive Disorder

MeSH Terms

Attentional BiasAdultAntidepressive AgentsDepressive Disorder, MajorMajor Depressive DisorderFemaleHumansKetamineMaleMiddle AgedReproducibility of ResultsYoung AdultAdministration, Intravenous

Keywords

KetamineAntidepressantAttentional biasPsychologyMedicineAnesthesiaNeuroscienceCognitionHippocampusDepressionPsychedelicsIntravenous KetamineRapid-acting AntidepressantsReplication And Reproducibility

Sustainable Development Goals

SDG 0: Good health and well-being